Count on us for updates on the coronavirus and guidance for cancer patients and family members.Read the latest articles
Dr. Gareth Morgan is director in Multiple Myeloma Research at Perlmutter Cancer Center and a professor of medicine at NYU Grossman School of Medicine. He is an internationally recognized clinician scientist with expertise in the field of molecular genetics and treatment of multiple myeloma. He has authored more than 450 articles in high-impact peer-reviewed journals. Previously, Dr. Morgan was at Myeloma Center in 2014 from The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research in London where he was the Director of the Centre for Myeloma Research.
Dr. Morgan’s current research is based on characterizing the myeloma genome to identify disease drivers, which can be used to define specific subsets of disease and to design personalized therapeutic strategies against each subtype. He has developed, used, and audited novel molecular techniques including sensitive PCR based tests, molecular cytogenetics, expression microarrays, and more recently, NGS based mutational analysis suitable for application to the peripheral blood.
Dr. Morgan’s other research interests include molecular genetics, myeloma bone disease, intraclonal heterogeneity, the inherited basis of myeloma, and clinical trials. His research aims to cure myeloma by targeting treatment to the biology underlying each patient’s cancer.
Dr. Morgan received his doctorate on the genetics of leukemia from the University of London in 1991 and his bachelor of medicine in 1981 from the Welsh National School of Medicine. His post graduate medical training was completed in Wales and at the Royal Postgraduate Medical School in London.